Please enable JavaScript to continue using this application.

Compare $AVXL vs $TNYA | Chartloom

Compare

$AVXL vs $TNYA

Anavex Life Sciences Corp · Tenaya Therapeutics Inc

AVXL

Anavex Life Sciences Corp

TNYA

Tenaya Therapeutics Inc

Compare $AVXL vs $TNYA

Comparing Anavex Life Sciences Corp and Tenaya Therapeutics Inc

AVXLAnavex Life Sciences Corp

TNYATenaya Therapeutics Inc

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

TNYA

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

TNYA

Tenaya Therapeutics Inc

Market Cap

AVXL$138M

TNYA$126M

Enterprise Value

AVXL$20M

TNYA$48M

Price

AVXL$1.49

TNYA$0.58

P/E Ratio

AVXLN/A

TNYAN/A

P/S Ratio

AVXL0.00x

TNYA94.33x

EV/Sales

AVXL0.00x

TNYA35.84x

EV/EBITDA

AVXL0.00x

TNYA0.00x

P/B Ratio

AVXL1.50x

TNYA1.82x

P/FCF Ratio

AVXLN/A

TNYAN/A

EV/FCF

AVXL-0.67x

TNYA-0.91x

PEG Ratio

AVXLN/A

TNYAN/A

Forward P/E (NTM)

AVXLN/A

TNYAN/A

Forward P/S (NTM)

AVXLN/A

TNYA20.11x

Revenue (TTM)

AVXL$0

TNYA$1M

Revenue Growth (YoY)

AVXLN/A

TNYAN/A

Forward Rev Growth

AVXL377.5%

TNYA-49.9%

Gross Margin (TTM)

AVXL0.0%

TNYA0.0%

Operating Margin (TTM)

AVXL0.0%

TNYA0.0%

EBITDA Margin (TTM)

AVXL0.0%

TNYA-5657.2%

Net Margin (TTM)

AVXL0.0%

TNYA-7724.0%

FCF Margin (TTM)

AVXLN/A

TNYA-3939.2%

Net Income (TTM)

AVXL$-13M

TNYA$-103M

FCF (TTM)

AVXL$-29M

TNYA$-53M

EPS (TTM)

AVXL-$0.14

TNYA-$0.47

ROE (TTM)

AVXL-1143.0%

TNYA-10805.0%

ROA (TTM)

AVXL-1072.0%

TNYA-8584.0%

ROIC (TTM)

AVXL-1143.0%

TNYA-10805.0%

Cash

AVXL$118M

TNYA$78M

Debt

AVXL$0

TNYA$0

Net Cash/Debt

AVXL$118M

TNYA$78M

Current Ratio (TTM)

AVXL15.62x

TNYA4.52x

Quick Ratio (TTM)

AVXL15.51x

TNYA4.34x

Debt/Equity (TTM)

AVXL0.00x

TNYA0.00x

Debt/Assets (TTM)

AVXL0.0%

TNYA0.0%

Interest Coverage (TTM)

AVXLN/A

TNYAN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

TNYA0.00x

Beta

AVXL1.20

TNYA2.87

52W Performance

AVXL-84.9%

TNYA-68.3%

YTD Performance

AVXL-59.5%

TNYA-21.0%

% from 52W High

AVXL-85.0%

TNYA-75.3%

% from 52W Low

AVXL3.5%

TNYA11.4%

Asset Turnover (TTM)

AVXL0.00x

TNYA0.00x

FCF Yield (TTM)

AVXL-21.2%

TNYA-41.8%

Earnings Yield (TTM)

AVXL-9.4%

TNYA-81.9%

Dividend Yield (TTM)

AVXLN/A

TNYAN/A

Rule of 40

AVXL0.0

TNYA-3,939.2

EV/GP/RG

AVXLN/A

TNYAN/A

Ticker research

View AVXL research View TNYA research

Metric	AVXL Anavex Life Sciences Corp	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$138M	$126M
Enterprise Value	$20M	$48M
Price	$1.49	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	94.33x
EV/Sales	0.00x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-13M	$-103M
FCF (TTM)	$-29M	$-53M
EPS (TTM)	-$0.14	-$0.47
ROE (TTM)	-1143.0%	-10805.0%
ROA (TTM)	-1072.0%	-8584.0%
ROIC (TTM)	-1143.0%	-10805.0%
Financial Health
Cash	$118M	$78M
Debt	$0	$0
Net Cash/Debt	$118M	$78M
Current Ratio (TTM)	15.62x	4.52x
Quick Ratio (TTM)	15.51x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.87
52W Performance	-84.9%	-68.3%
YTD Performance	-59.5%	-21.0%
% from 52W High	-85.0%	-75.3%
% from 52W Low	3.5%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-41.8%
Earnings Yield (TTM)	-9.4%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View TNYA research

Valuation

P/S Ratio

AVXL

0.00x

TNYA

94.33x

EV/FCF

TNYA

-0.91x

AVXL

-0.67x

Growth & revenue

Forward Revenue Growth

AVXL

377.5%

TNYA

-49.9%

Profitability & performance

Gross Margin

AVXL

0.0%

TNYA

0.0%

ROE

AVXL

-1143.0%

TNYA

-10805.0%

FCF Yield %

AVXL

-21.2%

TNYA

-41.8%

52-Week Performance

TNYA

-68.3%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

TNYA

Tenaya Therapeutics Inc

Market Cap

AVXL$138M

TNYA$126M

Enterprise Value

AVXL$20M

TNYA$48M

Price

AVXL$1.49

TNYA$0.58

P/E Ratio

AVXLN/A

TNYAN/A

P/S Ratio

AVXL0.00x

TNYA94.33x

EV/Sales

AVXL0.00x

TNYA35.84x

EV/EBITDA

AVXL0.00x

TNYA0.00x

P/B Ratio

AVXL1.50x

TNYA1.82x

P/FCF Ratio

AVXLN/A

TNYAN/A

EV/FCF

AVXL-0.67x

TNYA-0.91x

PEG Ratio

AVXLN/A

TNYAN/A

Forward P/E (NTM)

AVXLN/A

TNYAN/A

Forward P/S (NTM)

AVXLN/A

TNYA20.11x

Revenue (TTM)

AVXL$0

TNYA$1M

Revenue Growth (YoY)

AVXLN/A

TNYAN/A

Forward Rev Growth

AVXL377.5%

TNYA-49.9%

Gross Margin (TTM)

AVXL0.0%

TNYA0.0%

Operating Margin (TTM)

AVXL0.0%

TNYA0.0%

EBITDA Margin (TTM)

AVXL0.0%

TNYA-5657.2%

Net Margin (TTM)

AVXL0.0%

TNYA-7724.0%

FCF Margin (TTM)

AVXLN/A

TNYA-3939.2%

Net Income (TTM)

AVXL$-13M

TNYA$-103M

FCF (TTM)

AVXL$-29M

TNYA$-53M

EPS (TTM)

AVXL-$0.14

TNYA-$0.47

ROE (TTM)

AVXL-1143.0%

TNYA-10805.0%

ROA (TTM)

AVXL-1072.0%

TNYA-8584.0%

ROIC (TTM)

AVXL-1143.0%

TNYA-10805.0%

Cash

AVXL$118M

TNYA$78M

Debt

AVXL$0

TNYA$0

Net Cash/Debt

AVXL$118M

TNYA$78M

Current Ratio (TTM)

AVXL15.62x

TNYA4.52x

Quick Ratio (TTM)

AVXL15.51x

TNYA4.34x

Debt/Equity (TTM)

AVXL0.00x

TNYA0.00x

Debt/Assets (TTM)

AVXL0.0%

TNYA0.0%

Interest Coverage (TTM)

AVXLN/A

TNYAN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

TNYA0.00x

Beta

AVXL1.20

TNYA2.87

52W Performance

AVXL-84.9%

TNYA-68.3%

YTD Performance

AVXL-59.5%

TNYA-21.0%

% from 52W High

AVXL-85.0%

TNYA-75.3%

% from 52W Low

AVXL3.5%

TNYA11.4%

Asset Turnover (TTM)

AVXL0.00x

TNYA0.00x

FCF Yield (TTM)

AVXL-21.2%

TNYA-41.8%

Earnings Yield (TTM)

AVXL-9.4%

TNYA-81.9%

Dividend Yield (TTM)

AVXLN/A

TNYAN/A

Rule of 40

AVXL0.0

TNYA-3,939.2

EV/GP/RG

AVXLN/A

TNYAN/A

Ticker research

View AVXL research View TNYA research

Metric	AVXL Anavex Life Sciences Corp	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$138M	$126M
Enterprise Value	$20M	$48M
Price	$1.49	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	94.33x
EV/Sales	0.00x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	377.5%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-13M	$-103M
FCF (TTM)	$-29M	$-53M
EPS (TTM)	-$0.14	-$0.47
ROE (TTM)	-1143.0%	-10805.0%
ROA (TTM)	-1072.0%	-8584.0%
ROIC (TTM)	-1143.0%	-10805.0%
Financial Health
Cash	$118M	$78M
Debt	$0	$0
Net Cash/Debt	$118M	$78M
Current Ratio (TTM)	15.62x	4.52x
Quick Ratio (TTM)	15.51x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.87
52W Performance	-84.9%	-68.3%
YTD Performance	-59.5%	-21.0%
% from 52W High	-85.0%	-75.3%
% from 52W Low	3.5%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.2%	-41.8%
Earnings Yield (TTM)	-9.4%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View TNYA research